MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Avanos Medical General and Administrative Expenses 2011-2026 | AVNS
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Avanos Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 316 M | 318 M | 335 M | 326 M | 300 M | 333 M | 399 M | 340 M | 322 M | 411 M | 398 M | 424 M | 351 M | 343 M | 352 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 424 M | 300 M | 351 M |
Quarterly General and Administrative Expenses Avanos Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77.6 M | 83.5 M | 75.7 M | - | 74.3 M | 80.9 M | 83.6 M | - | 78.7 M | 93 M | 88.8 M | - | 78.3 M | 83.2 M | 90.1 M | - | 75 M | 76.7 M | 73.4 M | - | 82.4 M | 76.9 M | 91.1 M | - | 94.4 M | 94.7 M | 106 M | - | 86.3 M | 79.8 M | 86.4 M | - | 78.4 M | 81.1 M | 84.8 M | - | 100 M | 108 M | 92.8 M | - | 97.2 M | 106 M | 97.2 M | - | 111 M | 101 M | 85.5 M | - | 82.5 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 111 M | 73.4 M | 87.5 M |
General and Administrative Expenses of other stocks in the Medical devices industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
1.76 B | $ 180.67 | 4.35 % | $ 13.5 B |  USA |
 |
Alphatec Holdings
ATEC
|
499 M | $ 11.25 | 3.21 % | $ 1.69 B | USA |
 |
Avinger
AVGR
|
14.1 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
15.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
AxoGen
AXGN
|
44.6 M | $ 33.47 | 4.72 % | $ 1.54 B | USA |
 |
BioSig Technologies
BSGM
|
67.5 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
28.8 M | - | - | $ 16.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
25.6 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
14.1 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
382 M | $ 12.32 | 1.23 % | $ 1.66 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.11 M | - | 3.58 % | $ 2.21 M | USA |
 |
EDAP TMS S.A.
EDAP
|
5.9 M | $ 3.33 | 0.76 % | $ 125 M |  France |
 |
Obalon Therapeutics, Inc.
OBLN
|
8.78 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
814 M | $ 288.17 | 3.19 % | $ 8.13 B | USA |
 |
Cytosorbents Corporation
CTSO
|
35.6 M | $ 0.59 | -4.08 % | $ 36.7 M | USA |
 |
Bruker Corporation
BRKR
|
894 M | $ 39.05 | 3.88 % | $ 5.82 K | USA |
 |
Boston Scientific Corporation
BSX
|
6.89 B | $ 63.18 | 2.3 % | $ 93.5 B | USA |
 |
Apollo Endosurgery
APEN
|
20.6 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
171 M | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
16.5 M | $ 10.01 | 15.32 % | $ 283 M | USA |
 |
Dynatronics Corporation
DYNT
|
8.46 M | - | 14.99 % | $ 929 K | USA |
 |
Second Sight Medical Products
EYES
|
1.11 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
39.3 M | $ 24.95 | 3.44 % | $ 211 M | USA |
 |
CryoLife, Inc.
CRY
|
141 M | - | -4.14 % | $ 702 M | USA |
 |
Soliton, Inc.
SOLY
|
8.46 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.88 K | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
8.88 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
8.5 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
18 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14.7 M | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
1.18 B | $ 92.98 | 2.83 % | $ 12.6 B | USA |
 |
Helius Medical Technologies
HSDT
|
9.27 M | $ 2.03 | 7.41 % | $ 1.23 M | USA |
 |
Butterfly Network
BFLY
|
39.8 M | $ 4.28 | 4.39 % | $ 906 M | USA |
 |
Intersect ENT, Inc.
XENT
|
98.6 M | - | - | $ 955 M | USA |
 |
Inogen
INGN
|
67.4 M | $ 6.45 | 1.9 % | $ 172 M | USA |
 |
IRIDEX Corporation
IRIX
|
7.73 M | $ 1.03 | 3.01 % | $ 17.4 M | USA |
 |
BIOLASE
BIOL
|
10.2 M | - | -13.19 % | $ 166 K | USA |
 |
OrthoPediatrics Corp.
KIDS
|
120 M | $ 16.95 | 6.14 % | $ 398 M | USA |
 |
Delcath Systems
DCTH
|
43.5 M | $ 10.45 | 4.08 % | $ 374 M | USA |
 |
Myomo
MYO
|
14 M | $ 0.73 | 6.34 % | $ 30.6 M | USA |
 |
Inspire Medical Systems
INSP
|
625 M | $ 54.92 | 1.67 % | $ 1.61 B | USA |
 |
CONMED Corporation
CNMD
|
132 M | $ 38.46 | 4.68 % | $ 1.19 B | USA |
 |
LivaNova PLC
LIVN
|
549 M | $ 64.58 | 2.87 % | $ 3.52 B |  Britain |
 |
LENSAR
LNSR
|
45.2 M | $ 5.92 | 3.86 % | $ 70.8 M | USA |
 |
Integer Holdings Corporation
ITGR
|
212 M | $ 87.73 | 3.08 % | $ 3.05 B | USA |
 |
FONAR Corporation
FONR
|
23.5 M | $ 18.71 | 0.16 % | $ 123 M | USA |
 |
Invacare Corporation
IVC
|
227 M | - | - | $ 24.7 M | USA |